Results 21 to 30 of about 239,825 (303)
British Journal of Surgery, 2002 OBJECTIVE: To review the literature addressing the problem of aspirin resistance in patients with vascular disease. DATA SOURCES: A MEDLINE search (1966–February 2002) was performed.
J, Smout, G, Stansby
openaire +5 more sources
Progress in Cardiovascular Diseases, 2009 The development of adverse cardiovascular events despite aspirin use has established an interest in a possible resistance to the drug. Several definitions have been set and various laboratory testing modalities are available. This has led to a wide range of prevalence reports in different clinical entities.
Udaya S, Tantry +2 more
openaire +5 more sources
The targets of aspirin in bladder cancer: bioinformatics analysis
BMC Urology, 2022 Background The anti-carcinogenic properties of aspirin have been observed in some solid tumors. However, the molecular mechanism of therapeutic effects of aspirin on bladder cancer is still indistinct. We introduced a bioinformatics analysis approach, to
Xiao Li +10 more
doaj +1 more source
The dissolution of aspirin and aspirin tablets
Journal of Pharmacy and Pharmacology, 1967 Abstract An attempt has been made to standardize the “beaker” method of measuring in vitro dissolution rates of tablets against published data for aspirin. An unexpected problem arose when it was found that samples of commercial aspirin have different intrinsic dissolution rates.
A G, Mitchell, D J, Saville
openaire +2 more sources
Thorax, 2000 Aspirin or acetylsalicylic acid (ASA) is still one of the most widely sold drugs in the world and its side effects are well known. Among these, hypersensitivity reactions represent one of the most frequently described since the first report of urticaria and angio-oedema by Hirshberg in 1902.1 The hypersensitivity reactions to aspirin may be divided ...
Nucera, Eleonora +6 more
openaire +4 more sources
Journal of Translational Medicine, 2008 Background Our previous publication showed that 9% of patients with a history of myocardial infarction MI. could be labeled as aspirin resistant; all of these patients were aspirin resistant because of non-compliance.
Reeves Mathew +4 more
doaj +1 more source
Application of low dose aspirin in pre-eclampsia
Frontiers in Medicine, 2023 Aspirin is widely used in the primary and secondary prevention of cardiovascular and cerebrovascular diseases. Low-dose aspirin is also widely used to prevent pre-eclampsia and fetal growth retardation in utero.
Yu Ren +4 more
doaj +1 more source
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer : a systematic review and overview of reviews [PDF]
, 2013 Background: Prophylactic aspirin has been considered to be beneficial in reducing the risks of heart disease and cancer. However, potential benefits must be balanced against the possible harm from side effects, such as bleeding and gastrointestinal (GI ...
Gurung, T. +19 more
core +1 more source
Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin [PDF]
Thrombosis, 2012 Acetyl salicylic acid or aspirin is one of the most famous drugs in the world. Aspirin has been increasingly used for prevention of cardiovascular events and is, particularly in recent decades, the most used nonsteroidal anti-inflammatory drug. Thus, it was necessary to have several contributions to precise the interest and the side effects of ...
openaire +2 more sources
eJHaem, 2022 Major bleeding is linked to poorer outcomes following cardiac surgery. Current guidelines recommend continuation of aspirin prior to coronary artery by‐pass graft (CABG) but the effect of continuing aspirin in patients with prior indication for aspirin ...
Christopher Little +5 more
doaj +1 more source